Press Release

UAE Next Generation Sequencing Market to grow with a CAGR of 14.83%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Next Generation Sequencing Market.

According to TechSci Research report, “UAE Next Generation Sequencing Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Next Generation Sequencing Market has valued at USD 0.13 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 14.83% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

The field of bioinformatics and data analysis solutions plays a pivotal role in driving the demand for Next Generation Sequencing (NGS). NGS generates vast amounts of data in the form of raw sequencing reads. Bioinformatics tools are essential for processing, filtering, and managing these large datasets efficiently. Bioinformatics solutions are crucial for assembling short sequencing reads into complete genomes and mapping them to reference genomes. This is fundamental for understanding the genomic structure and identifying variations. Identifying genetic variants, such as single nucleotide polymorphisms (SNPs) and insertions/deletions (indels), is a key aspect of NGS data analysis. Bioinformatics tools are used for variant calling, and annotating these variants provides insights into their potential functional significance.

Bioinformatics enables the analysis of functional genomics data, including the identification of genes, regulatory elements, and pathways implicated in specific biological processes. This is essential for understanding the functional implications of genomic variations. NGS data analysis involves the detection of structural variants, such as copy number variations (CNVs) and chromosomal rearrangements. Bioinformatics tools are used to identify and interpret these structural variations.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Next Generation Sequencing Market.

In March 2023, The UAE has initiated its National Genome Strategy, designed to establish a thorough legislative and governance framework facilitating the creation and execution of genomic programs. Spanning a decade, the strategy aims to address public health priorities and enhance the nation's overall well-being. Oversight for the National Genome Strategy is vested in the Emirates Genome Council, formed in 2021, which has made substantial strides in establishing the foundation for regulatory, research, technological, and medical institutions to foster connectivity, collaboration, and the development of advanced medical applications and services.

Patient consent and engagement represent crucial aspects of ethical and legal considerations in the Next Generation Sequencing (NGS) market. In the United Arab Emirates (UAE), as in many other regions, there are several challenges related to obtaining informed consent from patients and engaging them effectively in the context of genomic testing. Patients may express concerns about the privacy and security of their genetic information. The sensitive nature of genomic data raises apprehensions about how the information will be handled, stored, and protected from unauthorized access. NGS involves complex technologies and potential implications for patients and their families. Explaining the intricacies of NGS procedures, potential findings, and the long-term impact of genomic data may be challenging, making it difficult for patients to provide truly informed consent. Cultural factors play a significant role in patient perceptions and decision-making. There may be cultural sensitivities in discussing genetic information, and healthcare providers need to navigate these cultural nuances to ensure effective communication and consent.

UAE Next Generation Sequencing Market is segmented based on Product, Technology, Application, End User, and by region.  

Based on Technology, Sequencing by Synthesis, lon Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing, Others. Single Molecule Real Time Sequencing (SMRT Sequencing) is a third-generation sequencing technology developed by Pacific Biosciences (PacBio). Unlike traditional sequencing methods that rely on the detection of fluorescence signals during polymerization reactions, SMRT Sequencing directly observes the incorporation of nucleotides in real time from a single DNA molecule. This technology offers long read lengths and is known for its ability to generate highly accurate sequencing data. SMRT Sequencing utilizes a unique platform called Zero-Mode Waveguide (ZMW) arrays. ZMWs are tiny wells, each of which contains a single DNA polymerase enzyme immobilized at the bottom. The diameter of these wells is such that only a single DNA polymerase enzyme and its associated template DNA strand can fit inside.

Based on Region, Abu Dhabi region held the largest share in the UAE Next Generation Sequencing Market. The strategic location and economic factors, such as a stable economic environment and business-friendly policies, can attract investment and companies specializing in NGS technologies to operate in the region. Educational programs and training initiatives that focus on genomics and NGS technologies can contribute to the development of a skilled workforce. If Abu Dhabi has invested in such programs, it may enhance its capabilities in the NGS field. A supportive and clear regulatory environment for genomics and NGS applications can encourage businesses and research institutions to operate in a region. If Abu Dhabi has established favorable regulatory conditions, it may attract stakeholders in the NGS market.

Some of the major companies operating in the UAE Next Generation Sequencing Market include:

  • Oxford Nanopore UAE
  • Agiomix Labs
  • Illumina UAE
  • Thermo Fischer Scientific UAE
  • PerkinElmer UAE
  • Alliance Global UAE


Download free Sample Report

Customers can also request 10% free customization on this report.

“Certain areas, particularly in Dubai, are projected to exert significant demand for Next Generation Sequencing. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the UAE Next Generation Sequencing Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

UAE Next Generation Sequencing Market by Product (Consumables, Platforms, Services), By Technology (Sequencing by Synthesis, lon Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing, Others), By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, Others), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE Next Generation Sequencing Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE Next Generation Sequencing Market.


Mr. Ken Mathews

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602 

Email: [email protected]


Relevant News